Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook
Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell
使用调强螺旋断层放疗的全骨髓照射与全身照射,Journal of Cancer Research and Clinical Oncology - X-MOL
Volume 21, Issue 3, Pages (October 2017) - ppt download
Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging | Circulation: Cardiovascular Imaging
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
Immunotherapy as an advance in cancer medicine - Innovations Report
Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell Responses: Molecular Therapy
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report | SpringerLink
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
UKB NewsRoom | Auszeichnung für herausragende Krebsforscher + + + mehr:
Cardiac MRI in Suspected Acute COVID-19 Myocarditis
Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A Prospective Study
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherap
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
Implementing combinatorial immunotherapeutic regimens against cancer
Pacritinib protects dendritic cells more efficiently than ruxolitinib - Experimental Hematology
